Posts Tagged ‘PAHO’

Come observe Malaria Day in the Americas

October 28th, 2010

PAHEF, the Pan American Health Organization, and the George Washington University Center for Global Health are hosting an event next week to celebrate Malaria Day in the Americas.

Malaria in the Americas Forum 2010:

Counting Malaria Out– Promoting Best Practices and Collaboration

Featuring presentations by
Admiral R. Timothy Ziemer (USAID‐PMI)
Dr. Keith H. Carter (PAHO)
Dr. Yeni Otilia Herrera (MoH– Peru)

and videos & discussions on
AMI/RAVREDA*, and
The work of ‘Malaria Champions of the Americas 2010’

WHEN: Thursday, November 4, 2010
TIME: 1:30 p.m. to 5:00 p.m.
WHERE: Room B, Pan American Health Organization
525 23rd Street NW, Washington, DC 20037
RSVP: Please fill out the form here

Light refreshments will be served

Reading List 9/27/10

September 27th, 2010

Brand new reading list to help kick off your week! Today we’re reading about guinea worm eradication efforts that inspired the film Foul Water Fiery Serpent, health care needs in Africa, and the beginning of Pan American Health Organization (PAHO)’s week-long annual Directing Council meeting. Also, “Good Intentions,” a nonprofit that works to guide donors on making informed funding decisions, put together a comprehensive list of readings and blog posts on the Clinton Global Initiative and UN week.

Eradicating Guinea worm disease—a prelude to NTD elimination, David Molyneux, The Lancet
Saving Africa’s dying from the ‘brain drain’ , Jane Elliott, BBC News
Meeting of Ministers of Health of the Americas Starts Today, Pan American Health Organization
A Compilation of articles about Clinton Global Initiative and UN week, Good Intentions

Where’s my Jetpack?

May 25th, 2010

by: Alanna Shaikh

It’s 2010, and I still don’t have a jetpack. My car sticks stubbornly to the ground instead of flying. Food is still food, not high-tech pellets. And we still haven’t eliminated Chagas disease.

 On July 4th, 2007, the World Health organization launched an effort to eliminate Chagas disease by 2010. The effort included a new network devoted to fighting Chagas, which would expand successful efforts by the Pan American Health organization (PAHO) to control the disease.

 Three years later, Chagas is far from eliminated. It is endemic in 21 countries, and over seven million people are currently infected with the disease. True, we have seven more months left in 2010, but it seems unlikely we’ll treat a million people every month this year and get this thing done.

 What I find frustrating is that we failed at something with such a clearly defined scope. This isn’t the Millennium Development Goals here. We’re not trying to dramatically change life on this planet. We were just trying to get rid of one treatable disease that’s endemic only in Mexico and South America.

 So what happened?

 Chagas doesn’t have great drugs to treat it. The two drugs that work on Chagas – Nifurtimox and Benznidazole – aren’t 100% effective. They work best in early stages of the disease – they can cure up to 80% of people of you catch the disease early. If you wait until the Chagas is chronic, the cure rate goes down to 10-20%. That means you spend a lot of time, effort, and money on treatments that don’t work. In addition to wasting health system capacity, it’s not exactly an incentive to come in and get treated. The drugs also work better on kids than on adults.

 To make matters worse, Nifurtimox and Benznidazole have unpleasant side effects. They include some digestive stuff from Nifurtimox: stomach pain, anorexia, nausea, and vomiting and some terrifying blood and skin side effects from the Benznidazole: swelling, hypersensitive skin, and anemia. Again, really not an incentive to keep taking your drugs.

 Aside from drugs, you can take a surgical approach to Chagas. Needless to say, surgery for the disease is difficult, painful, risky, and expensive. It’s not a feasible approach to seven million people, many of which are children.

 If we’re going to eliminate Chagas, we need to develop better drugs. That didn’t happen in time for 2010 eradication, but the situation is not hopeless. The Drugs for Neglected Diseases initiative is working on Chagas. They plan to develop an easier to manage children’s version of benznidazole, investigate combination therapies for Chagas treatment, and develop at least one new drug for Chagas by 2014.

 Also we’ll be able to deliver the drug house-to-house via visiting nurses wearing jetpacks.

 Seriously, though – how do we make sure that the 2014 goals actually come true? We pay attention. We hold policymakers to their promises, track the progress of the Drugs for Neglected Diseases initiative, and notice if years pass by and the number of people with Chagas is still almost eight million.  

Alanna Shaikh is an expert in health consulting, writing about global health for UN Dispatch and about international relief and development at Blood & Milk. She also serves as a frequently contributing blogger to ‘End the Neglect.”

River Blindness Transmission Cycle Broken in Ecuador

March 4th, 2010

Just this week the Ministry of Health and several other partners in the Onchocerciasis Elimination Program for the Americas (OEPA) have declared onchocerciasis transmission has been halted in Ecuador. As per World Health Organization policy, Ecuador must now monitor and verify elimination for the next three years. In 2008, the Pan American Health Organization restated its dedication to eliminating river blindness in the Americas by 2012 and this announcement is an important step towards achieving that goal.

Onchocerciasis is transmitted by the bite of the black fly and a small, bite-transmitted worm parasite. This parasite, Onchocerca volvulus, causes skin irritation and can cause loss of sight. The illness is known as river blindness because the black flies breed in fast-moving bodies of water near affected communities. In order to break the disease transmission cycle, implementing organizations utilize the common practice of mass drug administration (MDA). In MDA programs, safe and affordable (often donated) drugs are distributed to entire communities several times a year. For onchocerciasis treatments, the Merck produced drug Mecitzan (ivermectan) is used at no cost. In the last twenty years over eight million doses have been distributed across the region in endemic communities.

OEPA is a regional collaboration that was started in 1993 by The Carter Center to treat the more than 500,000 people at risk for this disease across Latin America. The partnership includes the Pan American Health Organization (World Health Organization), the pharmaceutical company Merck, the Pan American Health and Education Foundation (PAHEF), Lions Clubs International Foundation, and the Bill and Melinda Gates Foundation. The OEPA program targets the six Latin American countries (Brazil, Ecuador, Guatemala, Mexico and Venezuela) where onchocerciasis is still a public health threat. Originally there were seven countries on this list, but Colombia achieved transmission interruption in 2008. In light of this week’s announcement, this list will be shortened to only five countries.

With a growing interest in the potential for elimination of onchocerciasis from Africa, the success of the programs in the Americas provides an experience base that can guide the next phase of the onchocerciasis program in Africa.

See Also: 

http://www.pahef.org/press/2010_river_blindness.html

http://www.aolnews.com/health/article/ecuador-halts-spread-of-river-blindness/19378514

http://www.cartercenter.org/news/pr/ecuador-030110.html